ITC (ITC) Q4 25/26 earnings summary

Executive summary

• Audited standalone and consolidated financial results for the quarter and year ended 31st March 2026 were approved, with unmodified opinions from statutory auditors.

• Final dividend of ₹8 per share recommended, bringing total FY26 dividend to ₹14.50 per share.

• Amalgamation of Sresta Natural Bioproducts and Wimco Limited completed, impacting segment comparability.

Financial highlights

• Standalone revenue from operations for FY26 was ₹84,927 crore, up from ₹77,693 crore year-over-year.

• Standalone net profit for FY26 was ₹20,286 crore, compared to ₹19,561 crore in FY25.

• Consolidated revenue from operations for FY26 was ₹92,339 crore, up from ₹84,142 crore year-over-year.

• Consolidated net profit for FY26 was ₹21,018 crore, compared to ₹19,808 crore in FY25.

• Earnings per share (EPS) for FY26: Standalone ₹16.20 (basic, continuing), Consolidated ₹16.52 (basic, continuing).

Outlook and guidance

• Board recommended a final dividend, with AGM scheduled for July 23, 2026.

• Dividend payout reflects continued strong cash generation.